{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T13:31:50Z","timestamp":1790688710629,"version":"4.1.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T00:00:00Z","timestamp":1725494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T00:00:00Z","timestamp":1725494400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Headache Pain"],"DOI":"10.1186\/s10194-024-01851-x","type":"journal-article","created":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T11:15:55Z","timestamp":1725534955000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Therapeutic effect of a single lumbar puncture in idiopathic intracranial hypertension"],"prefix":"10.1186","volume":"25","author":[{"given":"Sina","family":"Zaic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nik","family":"Krajnc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Macher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Michl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Mitsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Marik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Novak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"W\u00f6ber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berthold","family":"Pemp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Bsteh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,5]]},"reference":[{"issue":"4","key":"1851_CR1","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/S1042-3680(18)30161-X","volume":"10","author":"DI Friedman","year":"1999","unstructured":"Friedman DI (1999) Pseudotumor Cerebri. Neurosurg Clin N Am 10(4):609\u2013621 viii","journal-title":"Neurosurg Clin N Am"},{"issue":"3","key":"1851_CR2","first-page":"478","volume":"33","author":"SP Mollan","year":"2019","unstructured":"Mollan SP, Aguiar M, Evison F, Frew E, Sinclair AJ (2019) The expanding burden of idiopathic intracranial hypertension. Eye Lond Engl 33(3):478\u2013485","journal-title":"Eye Lond Engl"},{"key":"1851_CR3","doi-asserted-by":"crossref","unstructured":"Ab D, Gt L, Nj V, Sl G, Ml M, Nj N et al (2007) Profiles of obesity, weight gain, and quality of life in idiopathic intracranial hypertension (pseudotumor cerebri). Am J Ophthalmol [Internet]. Apr [cited 2024 Jun 2];143(4). https:\/\/pubmed.ncbi.nlm.nih.gov\/17386271\/","DOI":"10.1016\/j.ajo.2007.01.001"},{"issue":"6","key":"1851_CR4","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s11910-018-0839-1","volume":"18","author":"JG Burkett","year":"2018","unstructured":"Burkett JG, Ailani J (2018) An up to date review of Pseudotumor Cerebri Syndrome. Curr Neurol Neurosci Rep 18(6):33","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"13","key":"1851_CR5","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1212\/WNL.0b013e3182a55f17","volume":"81","author":"DI Friedman","year":"2013","unstructured":"Friedman DI, Liu GT, Digre KB (2013) Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and children. Neurology 81(13):1159\u20131165","journal-title":"Neurology"},{"issue":"3","key":"1851_CR6","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1097\/WNO.0000000000001373","volume":"41","author":"HE Moss","year":"2021","unstructured":"Moss HE, Margolin E, Lee AG, Van Stavern GP (2021) Should lumbar puncture be required to diagnose every patient with idiopathic intracranial hypertension? J neuro-ophthalmol off. J North Am Neuro-Ophthalmol Soc 41(3):379\u2013384","journal-title":"J North Am Neuro-Ophthalmol Soc"},{"issue":"2","key":"1851_CR7","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1177\/0333102418782192","volume":"39","author":"A Yiangou","year":"2019","unstructured":"Yiangou A, Mitchell J, Markey KA, Scotton W, Nightingale P, Botfield H et al (2019) Therapeutic lumbar puncture for headache in idiopathic intracranial hypertension: minimal gain, is it worth the pain? Cephalalgia Int J Headache 39(2):245\u2013253","journal-title":"Cephalalgia Int J Headache"},{"issue":"7","key":"1851_CR8","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1177\/0333102414550109","volume":"35","author":"HM Yri","year":"2015","unstructured":"Yri HM, Jensen RH (2015) Idiopathic intracranial hypertension: clinical nosography and field-testing of the ICHD diagnostic criteria. A case-control study. Cephalalgia Int J Headache 35(7):553\u2013562","journal-title":"Cephalalgia Int J Headache"},{"issue":"2","key":"1851_CR9","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1177\/0333102418787301","volume":"39","author":"J Hoffmann","year":"2019","unstructured":"Hoffmann J (2019) The utility of the lumbar puncture in idiopathic intracranial hypertension. Cephalalgia Int J Headache 39(2):171\u2013172","journal-title":"Cephalalgia Int J Headache"},{"issue":"11","key":"1851_CR10","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1097\/01.brs.0000164099.92112.29","volume":"30","author":"JD Childs","year":"2005","unstructured":"Childs JD, Piva SR, Fritz JM (2005) Responsiveness of the Numeric Pain Rating Scale in patients with low back Pain. Spine 30(11):1331\u20131334","journal-title":"Spine"},{"issue":"2","key":"1851_CR11","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S0304-3959(01)00349-9","volume":"94","author":"JT Farrar","year":"2001","unstructured":"Farrar JT, Young JP, LaMoreaux L, Werth JL, Poole MR (2001) Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain 94(2):149\u2013158","journal-title":"Pain"},{"issue":"8","key":"1851_CR12","first-page":"963","volume":"12","author":"M Kosinski","year":"2003","unstructured":"Kosinski M, Bayliss MS, Bjorner JB, Ware JE, Garber WH, Batenhorst A et al (2003) A six-item short-form survey for measuring headache impact: the HIT-6. Qual Life Res Int J Qual Life Asp Treat Care Rehabil 12(8):963\u2013974","journal-title":"Qual Life Res Int J Qual Life Asp Treat Care Rehabil"},{"issue":"8","key":"1851_CR13","first-page":"975","volume":"12","author":"B Gandek","year":"2003","unstructured":"Gandek B, Alacoque J, Uzun V, Andrew-Hobbs M, Davis K (2003) Translating the short-form headache impact test (HIT-6) in 27 countries: methodological and conceptual issues. Qual Life Res Int J Qual Life Asp Treat Care Rehabil 12(8):975\u2013979","journal-title":"Qual Life Res Int J Qual Life Asp Treat Care Rehabil"},{"issue":"1\u20132","key":"1851_CR14","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/s00508-023-02252-x","volume":"136","author":"P Pruckner","year":"2024","unstructured":"Pruckner P, Mitsch C, Macher S, Krajnc N, Marik W, Novak K et al (2024) The Vienna idiopathic intracranial hypertension database\u2014An Austrian registry. Wien Klin Wochenschr 136(1\u20132):32\u201339","journal-title":"Wien Klin Wochenschr"},{"issue":"1","key":"1851_CR15","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1136\/jnnp.45.1.13","volume":"45","author":"L Frisen","year":"1982","unstructured":"Frisen L (1982) Swelling of the optic nerve head: a staging scheme. J Neurol Neurosurg Psychiatry 45(1):13\u201318","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"8","key":"1851_CR16","doi-asserted-by":"publisher","first-page":"3278","DOI":"10.1167\/iovs.02-1100","volume":"44","author":"DA Rosser","year":"2003","unstructured":"Rosser DA, Cousens SN, Murdoch IE, Fitzke FW, Laidlaw DAH (2003) How sensitive to clinical change are ETDRS logMAR visual acuity measurements? Invest Ophthalmol Vis Sci 44(8):3278\u20133281","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"1851_CR17","doi-asserted-by":"publisher","first-page":"e34823","DOI":"10.1371\/journal.pone.0034823","volume":"7","author":"P Tewarie","year":"2012","unstructured":"Tewarie P, Balk L, Costello F, Green A, Martin R, Schippling S et al (2012) The OSCAR-IB consensus criteria for retinal OCT quality assessment. PLoS ONE 7(4):e34823","journal-title":"PLoS ONE"},{"issue":"2","key":"1851_CR18","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1212\/WNL.0000000000012125","volume":"97","author":"A Aytulun","year":"2021","unstructured":"Aytulun A, Cruz-Herranz A, Aktas O, Balcer LJ, Balk L, Barboni P et al (2021) APOSTEL 2.0 recommendations for reporting quantitative Optical Coherence Tomography studies. Neurology 97(2):68\u201379","journal-title":"Neurology"},{"issue":"7","key":"1851_CR19","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1007\/s00417-013-2337-0","volume":"251","author":"B Pemp","year":"2013","unstructured":"Pemp B, Kardon RH, Kircher K, Pernicka E, Schmidt-Erfurth U, Reitner A (2013) Effectiveness of averaging strategies to reduce variance in retinal nerve fibre layer thickness measurements using spectral-domain optical coherence tomography. Graefes Arch Clin Exp Ophthalmol 251(7):1841\u20131848","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"5 Suppl","key":"1851_CR20","first-page":"807","volume":"98","author":"Classification of diabetic retinopathy from fluorescein angiograms","year":"1991","unstructured":"Classification of diabetic retinopathy from fluorescein angiograms (1991) ETDRS report number 11. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology 98(5 Suppl):807\u2013822","journal-title":"Ophthalmology"},{"key":"1851_CR21","first-page":"203","volume":"14","author":"KC Ossoinig","year":"1975","unstructured":"Ossoinig KC (1975) A-scan echography and orbital disease. Mod Probl Ophthalmol 14:203\u2013235","journal-title":"Mod Probl Ophthalmol"},{"issue":"Pt 4","key":"1851_CR22","first-page":"358","volume":"2","author":"HR Atta","year":"1988","unstructured":"Atta HR (1988) Imaging of the optic nerve with standardised echography. Eye Lond Engl 2(Pt 4):358\u2013366","journal-title":"Eye Lond Engl"},{"issue":"5","key":"1851_CR23","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1136\/jnnp-2011-302029","volume":"83","author":"V Biousse","year":"2012","unstructured":"Biousse V, Bruce BB, Newman NJ (2012) Update on the pathophysiology and management of idiopathic intracranial hypertension. J Neurol Neurosurg Psychiatry 83(5):488\u2013494","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5","key":"1851_CR24","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1136\/neurintsurg-2012-010468","volume":"5","author":"RC Puffer","year":"2013","unstructured":"Puffer RC, Mustafa W, Lanzino G (2013) Venous sinus stenting for idiopathic intracranial hypertension: a review of the literature. J Neurointerventional Surg 5(5):483\u2013486","journal-title":"J Neurointerventional Surg"},{"issue":"1","key":"1851_CR25","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1093\/imammb\/dql025","volume":"24","author":"SA Stevens","year":"2007","unstructured":"Stevens SA, Previte M, Lakin WD, Thakore NJ, Penar PL, Hamschin B (2007) Idiopathic intracranial hypertension and transverse sinus stenosis: a modelling study. Math Med Biol J IMA 24(1):85\u2013109","journal-title":"Math Med Biol J IMA"},{"issue":"10","key":"1851_CR26","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.clineuro.2011.05.015","volume":"113","author":"M Waisbourd","year":"2011","unstructured":"Waisbourd M, Leibovitch I, Goldenberg D, Kesler A (2011) OCT assessment of morphological changes of the optic nerve head and macula in idiopathic intracranial hypertension. Clin Neurol Neurosurg 113(10):839\u2013843","journal-title":"Clin Neurol Neurosurg"},{"issue":"3","key":"1851_CR27","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1136\/bjo.2010.199562","volume":"96","author":"CV Vartin","year":"2012","unstructured":"Vartin CV, Nguyen AM, Balmitgere T, Bernard M, Tilikete C, Vighetto A (2012) Detection of mild papilloedema using spectral domain optical coherence tomography. Br J Ophthalmol 96(3):375\u2013379","journal-title":"Br J Ophthalmol"},{"issue":"12","key":"1851_CR28","doi-asserted-by":"publisher","first-page":"8173","DOI":"10.1167\/iovs.14-14961","volume":"55","author":"P Auinger","year":"2014","unstructured":"OCT Sub-Study Committee for NORDIC Idiopathic Intracranial Hypertension Study Group, Auinger P, Durbin M, Feldon S, Garvin M, Kardon R et al (2014) Baseline OCT measurements in the idiopathic intracranial hypertension treatment trial, part II: correlations and relationship to clinical features. Invest Ophthalmol Vis Sci 55(12):8173\u20138179","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"1851_CR29","doi-asserted-by":"publisher","first-page":"32","DOI":"10.3390\/brainsci14010032","volume":"14","author":"SR Kerscher","year":"2023","unstructured":"Kerscher SR, Zipfel J, Bevot A, Sollmann N, Haas-Lude K, Tellermann J et al (2023) Non-invasive quantitative approximation of intracranial pressure in Pediatric Idiopathic Intracranial Hypertension based on point-of-care Ultrasound of the Optic nerve sheath diameter. Brain Sci 14(1):32","journal-title":"Brain Sci"},{"key":"1851_CR30","doi-asserted-by":"publisher","first-page":"118069","DOI":"10.1016\/j.jns.2021.118069","volume":"430","author":"S Knodel","year":"2021","unstructured":"Knodel S, Roemer SN, Moslemani K, Wykrota A, K\u00e4smann-Kellner B, Seitz B et al (2021) Sonographic and ophthalmic assessment of optic nerve in patients with idiopathic intracranial hypertension: a longitudinal study. J Neurol Sci 430:118069","journal-title":"J Neurol Sci"},{"issue":"8","key":"1851_CR31","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1111\/head.13153","volume":"57","author":"DI Friedman","year":"2017","unstructured":"Friedman DI, Quiros PA, Subramanian PS, Mejico LJ, Gao S, McDermott M et al (2017) Headache in idiopathic intracranial hypertension: findings from the idiopathic intracranial hypertension treatment trial. Headache 57(8):1195\u20131205","journal-title":"Headache"},{"issue":"5","key":"1851_CR32","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1111\/head.14478","volume":"63","author":"G Bsteh","year":"2023","unstructured":"Bsteh G, Macher S, Krajnc N, Pruckner P, Marik W, Mitsch C et al (2023) Idiopathic intracranial hypertension presenting with migraine phenotype is associated with unfavorable headache outcomes. Headache 63(5):601\u2013610","journal-title":"Headache"},{"issue":"1","key":"1851_CR33","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s10194-024-01799-y","volume":"25","author":"N Krajnc","year":"2024","unstructured":"Krajnc N, Frank F, Macher S, Michl M, M\u00fcller N, Maier S et al (2024) Plasma calcitonin gene-related peptide levels in idiopathic intracranial hypertension: an exploratory study. J Headache Pain 25(1):92","journal-title":"J Headache Pain"}],"container-title":["The Journal of Headache and Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-024-01851-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s10194-024-01851-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-024-01851-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T11:16:19Z","timestamp":1725534979000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejournalofheadacheandpain.biomedcentral.com\/articles\/10.1186\/s10194-024-01851-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,5]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1851"],"URL":"https:\/\/doi.org\/10.1186\/s10194-024-01851-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4848549\/v1","asserted-by":"object"}]},"ISSN":["1129-2377"],"issn-type":[{"value":"1129-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,5]]},"assertion":[{"value":"2 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"<b>Sina Zaic<\/b>: declares no conflict of interest relevant to this study.<b>Nik Krajnc<\/b>: has participated in meetings sponsored by, received speaker honoraria or travel funding from Alexion, BMS\/Celgene, Janssen-Cilag, Merck, Novartis, Roche and Sanofi-Genzyme and held a grant for a Multiple Sclerosis Clinical Training Fellowship Programme from the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS).<b>Stefan Macher<\/b>: declares no conflict of interest relevant to this study.<b>Martin Michl<\/b>: declares no conflict of interest relevant to this study.<b>Nina M\u00fcller<\/b>: declares no conflict of interest relevant to this study.<b>Christoph Mitsch<\/b>: declares no conflict of interest relevant to this study.<b>Wolfgang Marik<\/b>: declares no conflict of interest relevant to this study.<b>Klaus Novak<\/b>: declares no conflict of interest relevant to this study.<b>Christian W\u00f6ber<\/b>: has received honoraria consultancy\/speaking from Apomedica, Curelator.<b>Berthold Pemp<\/b>: declares no conflict of interest relevant to this study.<b>Gabriel Bsteh<\/b>: has participated in meetings sponsored by, received speaker honoraria or travel funding from Biogen, Celgene\/BMS, Lilly, Merck, Novartis, Roche, Sanofi-Genzyme and Teva, and received honoraria for consulting Biogen, Celgene\/BMS, Novartis, Roche, Sanofi-Genzyme and Teva. He has received unrestricted research grants from Celgene\/BMS and Novartis.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"145"}}